ZCA1 tcrb-J (M1); february 13-14, 2019; DR. JUN fang; bethesda north marriott hotel & conference center; total hotel cost complies with HHS policy on promoting efficient spending as of 1/3/2012
Ended Awarded Last action
- Contract number
- 75N91019F00129
- Awardee
-
Bsrep II MBN LLC UEI TRP2FSD3MF43
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,129
Award facts
- Contract value 100% obligated
- $16,129.09 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 721110 Hotels (except Casino Hotels) and Motels
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,615 | |
| Original award | $18,744 |
About this award
The National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), awarded a Blanket Purchase Agreement (BPA) call to Bsrep II MBN LLC, doing business as the Bethesda North Marriott Hotel & Conference Center, on December 18, 2018. This firm fixed-price contract, valued at approximately $16.1 thousand, was awarded without a set-aside designation and is set to expire on March 31, 2024. The contract covers hospitality services for a conference event (ZCA1 TCRB-J) held February 13-14, 2019, at the Bethesda North Marriott Hotel & Conference Center in Bethesda, Maryland, including accommodations and conference facilities for Dr. Jun Fang and associated attendees, with hotel costs compliant with HHS efficiency spending policies.
Bsrep II MBN LLC is a subsidiary of Marriott International specializing in providing federal government hospitality services, particularly for scientific peer review meetings and conferences across NIH institutes. The contractor maintains an extensive track record with the Department of Health and Human Services, serving agencies including the Center for Scientific Review and various NIH institutes through similarly structured BPA calls. The award was subsequently subject to a fund de-obligation directive issued December 4, 2023, per NIH Office of Administrative and Management Communications 24-16, to address expiring FY2019 funding lines.
Quick answers
Who was awarded contract 75N91019F00129?
75N91019F00129 was awarded to Bsrep II MBN LLC by National Cancer Institute (National Institutes of Health) on December 18, 2018.
How much is contract 75N91019F00129 worth?
The government has obligated $16,129 on 75N91019F00129.
Is contract 75N91019F00129 an order under another contract?
Yes. 75N91019F00129 is a BPA call under HHSN263201500186B, a blanket purchase agreement.
Was contract 75N91019F00129 competed?
The extent of competition for 75N91019F00129 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award